HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinico-morphological characteristics and results of treatment of endometrioid cystadenocarcinoma of the ovary].

Abstract
Clinico-morphological peculiarities of endometrioid cystadenocarcinoma of the ovaries (105 cases) were compared with those of a more frequent serous one. Hyperestrogenism was more frequent in endometrioid cystadenocarcinoma, metastases, ascites and hydrothorax developing less frequently. Immediate and long-term results in endometrioid cystadenocarcinoma were better than in cases of serous one. When hormone-producing, both tumors metastasized less frequently and 5-year survival rates in such cases were relatively higher. Progestin treatment was effective in cases of endometrioid cystadenocarcinoma, particularly, in those of hormone-producing form.
AuthorsV L Vinokurov, M A Livshits, E V Tsyrlina, A E Kolosov
JournalVoprosy onkologii (Vopr Onkol) Vol. 29 Issue 12 Pg. 49-56 ( 1983) ISSN: 0507-3758 [Print] Russia (Federation)
Vernacular TitleKliniko-morfologicheskie osobennosti i rezul'taty lecheniia éndometrioidnoĭ tsistadenokartsinomy iaichnikov.
PMID6420990 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Progestins
  • Follicle Stimulating Hormone
Topics
  • Adenocarcinoma (mortality, physiopathology, therapy)
  • Antineoplastic Agents (therapeutic use)
  • Castration
  • Combined Modality Therapy
  • Cystadenocarcinoma (mortality, physiopathology, therapy)
  • Endometriosis (mortality, physiopathology, therapy)
  • Female
  • Follicle Stimulating Hormone (blood)
  • Humans
  • Menstruation
  • Middle Aged
  • Neoplasm Metastasis
  • Ovarian Neoplasms (mortality, physiopathology, therapy)
  • Progestins (therapeutic use)
  • Prognosis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: